ICMR Calls for Expansion of Clinical Research Network Across India

Clinical trials conducted under the INTENT network encompass a wide range of areas, including drugs, devices, vaccines, and biologics. 

The Indian Council of Medical Research (ICMR) has called for expressions of interest (EOI) to broaden the scope of the Indian Clinical Trial and Education Network (INTENT). 

This network, initiated by the ICMR, serves as a collaborative platform for medical colleges, hospitals, and research institutes to conduct scientifically rigorous clinical trials addressing critical health issues.

The INTENT network, currently comprising 47 institutes nationwide, focuses on providing evidence-based solutions to national health priorities. 

However, recognizing the necessity for broader participation and enhanced capacity, the ICMR seeks to expand the network by inviting both public and private medical research institutes to contribute to its activities.

Clinical trials conducted under the INTENT network encompass a wide range of areas, including drugs, devices, vaccines, and biologics. 

These trials, developed in collaboration with academia, startups, or industry partners, aim to address pressing health concerns, including rare genetic diseases, with the potential to influence national health policies.

Under the coordination of the Clinical Studies & Trials Unit (CSTU) within the ICMR, selected centers from the EOI applicants will receive priority as trial sites. 

The network will centrally provide essential study support services such as data management, statistical support, insurance coverage, and regulatory advice. 

Financial support will be allocated based on individual clinical research projects, ensuring the necessary resources for their successful execution.

An ICMR official emphasized the significance of the initiative, stating that medical research institutes across the country are gearing up to participate in this landmark initiative. 

Advancing Medical Science for Public Health

As India faces diverse health challenges, the expansion of the INTENT network is viewed as a crucial step towards leveraging the collective expertise of medical institutions nationwide to address these issues effectively. 

The initiative underscores India's commitment to advancing medical science and improving public health outcomes.

The ICMR's call for the expansion of the INTENT network signifies a concerted effort to strengthen clinical research capabilities across India. 

By fostering collaboration among medical institutions and prioritizing evidence-based solutions, the initiative aims to address pressing health concerns and contribute to the advancement of medical science for the betterment of public health.

In another development, in March this year, ICMR, along with the Central Drugs Standard Control Organization (CDSCO) and MedTech Mitra, have joined forces to boost In Vitro Diagnostics (IVDs) standards in India.

The strategic collaboration between ICMR and CDSCO under the MedTech Mitra initiative seeks to address the challenges inherent in India's diagnostic sector. Moreover, the partnership is centered around establishing a robust testing and validation ecosystem.